Virology

HIV, HCV license agreement granted for plasma testing

Published in Hepatitis Weekly, August 11th, 2003

Chiron Corporation (CHIR) announced that it has granted to Baxter AG, a subsidiary of Baxter International, a license to use its HIV and hepatitis C virus (HCV) intellectual property in combination with Baxter's own technology for screening plasma for use with plasma fractionation in Europe.

These licenses will allow Baxter to continue to enhance and develop its own large-scale plasma-testing technology for screening plasma. The financial terms and other details of the license were not disclosed.

"This license represents the first usage of Chiron's intellectual property in plasma fractionation," said William G. Green, Esq., Chiron's general counsel....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2003-08-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry